Inscripta Stock
Inscripta® is a pioneering life science technology company dedicated to advancing the vision of a cleaner, healthier, and more sustainable world through biomanufacturing. As a globally recognized leader in genome engineering, Inscripta's ground-breaking innovations are specifically engineered to unlock the full potential of the bioeconomy. With an unwavering commitment to continuously advancing critical technologies, Inscripta empowers scientists to strengthen and broaden domestic biomanufacturing capabilities while also catalyzing the development of new, safe, and secure biotech innovations.
Sign up for SecondMarket™ to view the market and buy or sell Inscripta Stock
Buy + SellInscripta Funding
Sign up to gain insights into Inscripta funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Dec 13, 2022 | Series E | 27.79M | ||
| Mar 30, 2021 | Series E | 150.00M | ||
| Nov 27, 2019 | Series D | 92.15M | ||
| Apr 10, 2019 | Series C | 24.35M | ||
| Jan 04, 2019 | Series C | 25.65M | ||
| Feb 20, 2018 | Series C | 55.50M | ||
| Feb 16, 2017 | Series B | 23.00M | ||
| Apr 29, 2016 | Series A | 6.04M |
See Inscripta Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Inscripta Stock Valuation + Share Prices
View real-time Tape D™ data on Inscripta stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Inscripta Management Team
CFO, COO
Ed Tang
Chief Customer Officer
Aditya Phadke
CFO
Lisa Davidson
Chief Product & Technology Officer
Rohan Chandran
Director
Roger B Wyse
Director
Kristala Prather
President, CEO, Director
Sri Kosaraju
Chief Innovation Officer
Andrew Garst
Chief Technology Officer
Ted Tarasow
Director
Bryan E. Roberts
Chairman
John R. Stuelpnagel
Director
Scott Kupor
Director
Frank Slootman
Director
Toni Schneider
Inscripta Major Investors
NanoDimension Management, Ltd.
Merieux Developpement SASU
Spruce Capital Partners
MLS Capital (MLSF)
Foresite Capital Management LLC
Paladin Capital Group
JS Capital Management LLC
Venrock, Inc.
NanoDimension Management, Ltd.
Foresite Capital
Venrock, Inc.
Counterpoint Global
Fidelity Management & Research Company
Oak HC/FT Partners
Durable Capital Partners
D1 Capital Partners
Learn More About Inscripta Stock
Buy Inscripta Stock
01Inscripta stock does not trade on public stock exchanges. Inscripta stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Inscripta stock you can either buy shares directly through company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell Inscripta Stock
02Inscripta Stock does not trade on public stock exchanges. In order to sell Inscripta shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Inscripta Stock Price
03Inscripta does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Inscripta share price and other valuable private market data.
Read more about secondary market private company stock prices:
Inscripta Stock Ticker Symbol
04There is no ticker symbol for Inscripta stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell Inscripta Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Inscripta stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in Inscripta Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Inscripta stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Inscripta Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Inscripta IPO
08Inscripta is a private company and has not had an IPO. There is currently no Inscripta IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Inscripta IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket™ to view the market and buy or sell Inscripta Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
